about

  mission / vision

  history

  facility

accomplishments

our team

  board members

  executive leadership

  scientists

  profiles

careers

  life at IDRI

  benefits

  postdoctoral program

  internship program

  current job opportunities


Our Team

Board of Directors

Bruce Carter, PhD
Chair

Gail Cassell, PhD

Michel DeWilde, PhD

Christopher Hentschel, PhD

Erik Iverson, JD, LLM

David Perry, MBA
Executive Committee Member

Franklyn G. Prendergast, MD, PhD
Executive Committee Member

Massimo Radaelli, PhD

Steven G. Reed, PhD

Executive Leadership

BACK TO TOP

Christopher Antony
Vice President,
Operations
Environmental Health & Safety Officer


R. Douglas Bradley, PhD, JD
General Counsel
and Secretary


Anna Marie Beckmann, PhD
Vice President,
Development & Regulatory


Darrick Carter, PhD
Vice President,
Adjuvant Technology



Gail Cassell, PhD
Executive Vice President,
TB Drug Development


Rhea N. Coler, PhD
Vice President,
Preclinical Biology


Erik H. Iverson, JD, LLM
President, Business & Operations

Christopher Fox, PhD
Director, Formulations

Rob Lin, PhD, CFA
Vice President, Finance

Tanya Parish, PhD
Vice President,
Drug Discovery


Steven G. Reed, PhD
Founder, President, &
Chief Scientific Officer


Winston Wicomb, PhD, LATG
Director, Vivarium

Thomas Vedvick, PhD
Vice President, Formulation and Process Development




1616 Eastlake Avenue East, Suite 400, Seattle, Washington 98102 office@idri.org  |  P: (206) 381-0883  |  F: (206) 381-3678 © 1993-2016 Privacy Policy
Infectious Disease Research Institute